DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 04 · Volume 40 · November 2020 DOI: 10.1055/s-010-49668

Review Article

  • 331
    Adams, Leon A.; Chan, Wah-Kheong:

    Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future

  • 339
    Rowe, Ian A.:

    Histological Endpoints for Nonalcoholic Steatohepatitis Trials: Lights and Shadows

  • 346
    Ibrahim, Samar H.; Hirsova, Petra; Malhi, Harmeet; Gores, Gregory J.:

    Nonalcoholic Steatohepatitis Promoting Kinases

  • 358
    Heimbach, Julie K.:

    Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma

  • 365
    Freeburg, Scott H.; Goessling, Wolfram:

    Hepatobiliary Differentiation: Principles from Embryonic Liver Development

  • 373
    Maeso-Díaz, Raquel; Gracia-Sancho, Jordi:

    Aging and Chronic Liver Disease

  • 385
    Penrice, Daniel D.; Simonetto, Douglas A.:

    Short Telomeres: Cause and Consequence in Liver Disease

  • 392
    Pawlotsky, Jean-Michel; Ramers, Christian B.; Dillon, John F.; Feld, Jordan J.; Lazarus, Jeffrey V.:

    Simplification of Care for Chronic Hepatitis C Virus Infection

  • 403
    O'Brien, April; Gasheva, Olga; Alpini, Gianfranco; Zawieja, David; Gashev, Anatoliy; Glaser, Shannon:

    The Role of Lymphatics in Cholestasis: A Comprehensive Review

  • 411
    Khan, Sheeba; Khan, Reenam S.; Newsome, Philip N.:

    Cell Therapy for Liver Disease: From Promise to Reality